Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.03 - Poster Session 1 - Technology and Novel Development
- Type: Poster Session
- Track: Biology
- Presentations: 6
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.03-001 - Multiplexing technology for in situ biomarker profiling of Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): A. Sood
- Abstract
Loading...
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-017 - Clinical activity of lurbinectedin (PM01183) in combination with gemcitabine (GEM) in non-small cell lung cancer (NSCLC) patients (pts): preliminary subgroup analysis of a phase Ib study.
09:30 - 09:30 | Author(s): L. Paz-Ares
- Abstract
Loading...
-
+
O03 - NSCLC - Targeted Therapies I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:J. Ross
- Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium B, Level 1
-
+
O03.02 - Randomized Phase-3 trial (INSPIRE) of Necitumumab plus Cisplatin-Pemetrexed versus Cisplatin-Pemetrexed Alone as First-Line Therapy in Stage IV Non-Squamous NSCLC
10:40 - 10:50 | Author(s): L. Paz-Ares
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
E03 - Chemotherapy for NSCLC
- Type: Educational Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:R. Pirker
- Coordinates: 10/28/2013, 14:00 - 15:30, Bayside Auditorium A, Level 1
-
+
E03.2 - Selecting Patients for Maintenance Therapy
14:25 - 14:45 | Author(s): L. Paz-Ares
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO11 - Screening and Epidemiology
- Type: Mini Oral Abstract Session
- Track: Imaging, Staging & Screening
- Presentations: 13
- Moderators:P. Zimmerman
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 201 - 203, Level 2
-
+
MO11.11 - IL-11 and CCL-1: Novel protein diagnostic biomarkers of lung adenocarcinoma in bronchoalveolar lavage (BAL)
17:15 - 17:20 | Author(s): M. Pastor
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO12 - Prognostic and Predictive Biomarkers III
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 12
- Moderators:B. Han
- Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
MO12.07 - The prevalence of MET expression by immunohistochemistry (IHC) in the MetLung (OAM4971g) trial: a randomized, placebo-controlled, phase III study with erlotinib + onartuzumab (MetMAb) vs erlotinib + placebo in patients with previously treated non-small cell lung cancer (NSCLC)
11:10 - 11:15 | Author(s): M.J. Edelman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O15 - NSCLC - Chemotherapy II
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:G. Richardson
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1
-
+
O15.06 - Randomized Phase III Trial of Gemcitabine (G)/Carboplatin (C) with or without Iniparib (I) in Patients (Pts) with Previously Untreated Stage IV Squamous Lung Cancer
11:25 - 11:35 | Author(s): D. Spigel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O21 - SCLC II
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:M. Ahn
- Coordinates: 10/29/2013, 16:15 - 17:45, Parkside Ballroom B, Level 1
-
+
O21.05 - A multicenter, double-blind, placebo-controlled, randomized phase 2 study of ganitumab or rilotumumab with platinum-based chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC)
17:00 - 17:10 | Author(s): B. Glisson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
E11 - Practical Aspects of Targeted Therapies
- Type: Educational Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:M. Millward
- Coordinates: 10/30/2013, 14:00 - 15:30, Plenary Hall, Ground Level
-
+
E11.1 - Who Should We Test for Genetic Alterations, When and How?
14:00 - 14:20 | Author(s): R. Stahel
- Abstract
No abstract available for this presentation
-
+
E11.2 - Management Options at First Progression of EGFR Mutant Tumours
14:20 - 14:40 | Author(s): K. Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
E11.3 - Panel Discussion: MDT - Managing Toxicities and Evaluating Drug Interactions
14:40 - 14:55 | Author(s): P. Yang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
E11.3 - Panel Discussion: MDT - Managing Toxicities and Evaluating Drug Interactions
14:55 - 15:10 | Author(s): K. O'Byrne
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
E11.3 - Panel Discussion: MDT - Managing Toxicities and Evaluating Drug Interactions
15:10 - 15:25 | Author(s): A. Fraser
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
